The Indian Journal of Pediatrics

, 75:1133

Off-label drug use in children

  • Surabhi S. Jain
  • S. B. Bavdekar
  • Nithya J. Gogtay
  • Pranjali A. Sadawarte
Original Article

Abstract

Objective

To determine the extent and nature of off-label drug use in children admitted to a pediatric general ward in a tertiary health care centre

Methods

Consecutive patients aged 1 mo-12 years admitted to the general wards in a tertiary care center in Mumbai over a two-month period were prospectively enrolled in the study. British National Formulary [BNF] version 2005 was used to ascertain if the drug use was “off-label”. The off-label use was categorized as: administration of a greater/lesser dose, administration at a higher/lower frequency than indicated, administration for indications not described, administration of a drug not licensed for use in that age group and/ or use of alternative routes of administration. Descriptive statistics was used for calculating the off-label drug use.

Results

Two thousand prescriptions received by 600 subjects (M:F= 1.47:1) were analyzed. One thousand and forty-five (50.62%) prescriptions were off-label. The off-label drug use rate was 1.74+/−1.56 per patient. The maximum rate of off-label drugs was in infants (2.33/patient). ‘alteration in dosage’ was by far the commonest reason for off-label use; followed by ‘age’ and ‘indication’. Furosemide (i. v.), diazepam (i.v), cefotaxime (i.v), ethambutol (tab) and prednisolone (tab) were the five commonest off-label drugs used in the study population.

Conclusions

Off-label drug use was highly prevalent in general pediatric ward of a tertiary care hospital in India

Key words

Licensing Drug use Pediatrics Hospital-based Survey 

References

  1. 1.
    Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000; 320: 79–82PubMedCrossRefGoogle Scholar
  2. 2.
    BNF for Children 2005. London, BMJ Publishing Group, 2005Google Scholar
  3. 3.
    Mudur G. Indian Medical Association wants off-label prescribing. BMJ 2004; 328: 974.PubMedCrossRefGoogle Scholar
  4. 4.
    Sharma DC. Indian experts protest against off-label drug use. Lancet 2004; 363: 1372.PubMedCrossRefGoogle Scholar
  5. 5.
    Jhaj R, Bhargava VK, Uppal R, Lekha S, Reeta K, Kaur N. Use of cold medications for upper respiratory tract infections in children. Pharmacoepidemiol Drug Saf 2001; 10: 323–327.PubMedCrossRefGoogle Scholar
  6. 6.
    Turner S, Longworth A, Nunn A, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998; 316: 313–315.Google Scholar
  7. 7.
    Pandolfini C, Impicciatore P, Provasi DP, Rocchi F, Campi R, Bonati M, The Italian Pediatric Off-label Collaborative Group. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr 2002; 91: 339–347.PubMedCrossRefGoogle Scholar
  8. 8.
    ’t Jong GW, Vulto AG, De Hoog M, Schemmel KJ, Tibboel D, van den Anker JN. Unapproved and off-label use of drugs in a children’s hospital. New Engl J Med 2000; 343:1125PubMedCrossRefGoogle Scholar
  9. 9.
    Gavrilov V, Lifshitz M, Levy J, Gorodischer R. Unlicensed and off-label medication use in a general pediatric ambulatory hospital unit in Israel. Isr Med Assoc J 2000; 2: 595–597.PubMedGoogle Scholar
  10. 10.
    Craig JS, Henderson CR, Magee FA. The extent of unlicensed and off-label drug use in the pediatric ward of a district general hospital in Northern Ireland. Ir Med J 2001; 94:237–240 [abstract]PubMedGoogle Scholar
  11. 11.
    Conroy S, Peden V. Unlicensed and off-label analgesic use in pediatric pain management. Paediatr Anaesthesia 2001; 11: 431–436.CrossRefGoogle Scholar
  12. 12.
    Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs in pediatric wards: a prospective study. Acta Paediatr 1999; 88: 965–968.PubMedCrossRefGoogle Scholar
  13. 13.
    McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off-label prescribing of drugs in general practice. Arch Dis Child 2000; 83: 498–501.PubMedCrossRefGoogle Scholar
  14. 14.
    Conroy S, McIntyre J, Choonara I. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80: F142–F145.PubMedCrossRefGoogle Scholar
  15. 15.
    Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundamental and Clinical Pharmacology 2003; 17:125–131PubMedCrossRefGoogle Scholar
  16. 16.
    American Academy of Pediatrics. Committee on Drugs 2000–2001. Pediatrics 2002; 110: 181–183.CrossRefGoogle Scholar
  17. 17.
    Hill P. Off license and off label prescribing in children: litigation fears for physicians. Arch Dis Child 2005; 90: 17–18.CrossRefGoogle Scholar
  18. 18.
    Boos J. Off label use-label off use? Ann Oncol 2003; 14: 1–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Bavdekar SB, Gogtay NJ. Unlicensed and off-label drug use in children. J Postgrad Med 2005; 51:249–252.PubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2008

Authors and Affiliations

  • Surabhi S. Jain
    • 1
  • S. B. Bavdekar
    • 1
    • 3
  • Nithya J. Gogtay
    • 2
  • Pranjali A. Sadawarte
    • 1
  1. 1.Department of PediatricsSeth GS Medical College and KEM HospitalParel, MumbaiIndia
  2. 2.Department of Clinical PharmacologySeth GS Medical College and KEM HospitalParel, MumbaiIndia
  3. 3.Worli, MumbaiIndia

Personalised recommendations